B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS - M Mateos; P Hari; N Bahlis; A Chari; NWCJ van de Donk; B Dholaria; AL Garfall; H Goldschmidt; KM Kortüm; A Krishnan; T Martin; D Morillo; et al. (HemaSphere, 2022)